#PortfolioNews | NorthSea Therapeutics reports positive results from the Phase 2b ICONA trial of #Icosabutate in #MASH, published in the Journal of Hepatology!

📢 Read more: 👉 buff.ly/49eOq1j
📑 Full publication buff.ly/jZ9cXPW

#vc #fibrosis #metabolic